Breadcrumb Home Business activities 麻豆社 BioCapital 麻豆社 BioCapital Portfolio Dania Therapeutics Dania Therapeutics Dania Therapeutics is a preclinical company developing novel small molecule therapies to treat Acute myeloid leukemia (AML) and other life-threatening cancers. Relateret nyheder om Dania Therapeutics 18 October 2023 Venture forces invest millions in new type of treatment for particularly aggressive form of cancer Dania Therapeutics Invested 2023 Location Denmark Investors Hannibal Innovation, Vernalis, Eir Ventures, UCPH Ventures Contact Lars Gredsted Senior Principal lgr@lundbeckfonden.com Mobile +45 2479 2426 Liane Dupont Associate ldu@lundbeckfonden.com Mobile +45 5141 2812
